HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type 3 (chronic) GM1 gangliosidosis presenting as infanto-choreo-athetotic dementia, without epilepsy, in three sisters.

Abstract
Three sisters (ages 27, 24, and 17 years) presented with slowly progressing dystonic dementia and spastic tetraparesis with infantile onset. CSF, bone marrow, and conjunctival cells showed storage vacuoles. Biochemical analysis revealed increased urinary oligosaccharide excretion and decreased activity of acid beta-D-galactosidase and beta-D-fucosidase in serum, leukocytes, and cultured fibroblasts. The parents' enzyme values were in the heterozygous range. This is the only case in the literature of severe dementia associated with the clinical symptoms of type 3 GM1 gangliosidosis. The clinical heterogeneity of GM1 gangliosidosis and the significance of the combination of beta-D-galactosidase and beta-D-fucosidase defects in this syndrome are discussed.
AuthorsG C Guazzi, I D'Amore, F Van Hoof, C Fruschelli, C Alessandrini, S Palmeri, A Federico
JournalNeurology (Neurology) Vol. 38 Issue 7 Pg. 1124-7 (Jul 1988) ISSN: 0028-3878 [Print] United States
PMID3133574 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Oligosaccharides
  • G(M1) Ganglioside
  • beta-Galactosidase
  • alpha-L-Fucosidase
Topics
  • Adolescent
  • Adult
  • Bone Marrow (metabolism, pathology, ultrastructure)
  • Cells, Cultured
  • Conjunctiva (metabolism, pathology, ultrastructure)
  • Dementia (etiology, metabolism, pathology)
  • Female
  • Fibroblasts (metabolism)
  • G(M1) Ganglioside (metabolism)
  • Gangliosidoses (genetics, metabolism, pathology)
  • Humans
  • Leukocytes (enzymology)
  • Lysosomes (enzymology)
  • Microscopy, Electron
  • Oligosaccharides (urine)
  • Vacuoles (metabolism, ultrastructure)
  • alpha-L-Fucosidase (metabolism)
  • beta-Galactosidase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: